| Prev Close | 125.05 |
| Day Low/High | 122.12 / 129.80 |
| 52 Wk Low/High | 6.26 / 189.40 |
Novavax, Inc. (NVAX)
123.90
1.10
0.92
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 63.66B |
| Market Cap | 7.96B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Midday Report: Crude Stockpiles Rise for First Week in Nine; Stocks Rise
Stocks move cautiously higher as investors wait for direction from a number of market-churning events tomorrow.
Novavax's Chart Looked Good, Until It Didn't
Things were looking up and then today happened.
Look to Costamare for Value in Shipping
It's safe to say these guys know what they are doing.
The Good, The Bad And The Ugly
"Such ingratitude, after all the times I saved your life." -- Blondie, THE GOOD THE BAD THE UGLY Let's run down the good, the bad and the ugly in today's market so far: THE GOOD Bonds are trading better today. The 10- and 30-year bond yields are dow...
Underlying Risks in Speculative Bio Techs Can't Be Overstated
I have followed Novavax for several years. After yesterday's market close the company announced the results of their Phase Three trial for a respiratory-virus drug. NVAX missed its goal, and the shares are trading down by about 80% ($8.40 to $1) i...
Bought Aerie Earlier? Congratulations
An update on some recent small biotech recommendations.
4 Biotechs Set to Provide a Shot in the Arm
Each company has approaching catalysts.
4 Biotechs Set to Provide a Shot in the Arm
Each company has approaching catalysts.
3 Biotech-Investing Mistakes to Avoid
These are the biggest errors that I've made over the years.
4 Small-Cap Biotechs With Big Stories to Tell
Watch these names as stability returns to the sector.
My Takeaways and Observations
Another strong market day. The issue of taxes was front and center today. Here are some of my takes: My Take on Corporate Taxes Man Up, Allergan Shareholders Who Loses in Pfizer/Allergan Deal's Demise? I remain manifestly bearish, in the belief ...
Buying Biotechs
The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...
Jim Cramer Still Likes Home Depot, Kroger, But Tough to Buy Them Now
Jim Cramer talks oil, Citigroup, burger joints and biotechs.
Market Wrap: Stocks Retreat on China Devaluation
However, utilities and some technology names bucked the trend.
Twelve Posts of Christmas, Part 4
Piper's best stock picks, and some festive drinks.
Forget Calling a Bottom
Just be patient and protect capital.
Two Speculative Biotech Stocks
InterMune, Novavax have promising products and acquisition possibilities.
Sifting Through Small-Caps
These smaller companies with recent insider buying look intriguing.
Considering a Few Small-Cap Biotech Plays
The best way to invest in this sector is to accumulate small positions in at least a dozen firms.
